main content start

victor@rodrigues.com

0 Saved

Experience

0yrs

Location

Cetus Hospital-Dia Oncologia S/A

Groups

Upcoming Webinar

Start bookmarking content to consume it later

Start bookmarking content to consume it later

Start bookmarking content to consume it later

nasopharyngeal carcinoma • 46 Min Watch

Comprehensive Overview of Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (NPC) is an undifferentiated form of squamous cell carcinoma emerging from the epithelium of nasopharyn

nasopharyngeal carcinoma Immunotherapy

1

Watch Now

nasopharyngeal carcinoma • 46 Min Watch

Comprehensive Overview of Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (NPC) is an undifferentiated form of squamous cell carcinoma emerging from the epithelium of nasopharyn

nasopharyngeal carcinoma Immunotherapy

1

Watch Now

Breast Cancer • 45 Min Watch

Expert Perspective - How I Treat Metastatic Her2 Positive Breast Cancer

Anti-HER2 directed therapy remains the cornerstone of care for individuals with HER2-positive metastatic breast cancer (MBC). In the majority of cases...

anti-her2 directed therapy her2-positive metastatic breast cancer expert perspective algorithm for management of her2 positive mbc

2

Watch Now

Breast Cancer • 45 Min Watch

Expert Perspective - How I Treat Metastatic Her2 Positive Breast Cancer

Anti-HER2 directed therapy remains the cornerstone of care for individuals with HER2-positive metastatic breast cancer (MBC). In the majority of cases...

anti-her2 directed therapy her2-positive metastatic breast cancer expert perspective algorithm for management of her2 positive mbc

1

Watch Now

Myelodysplastic Syndromes • 34 Min Watch

Low Risk MDS - Key Practice Points

Myelodysplastic Syndromes (MDS) or Myeloproliferative Neoplasms show considerable heterogeneity with respect to presence of anemia , cytopenia & molec...

ipss -m low risk molecular features

1

Watch Now

Myelodysplastic Syndromes • 34 Min Watch

Low Risk MDS - Key Practice Points

Myelodysplastic Syndromes (MDS) or Myeloproliferative Neoplasms show considerable heterogeneity with respect to presence of anemia , cytopenia & molec...

ipss -m low risk molecular features

1

Watch Now

Breast Cancer • 45 Min Watch

Tumor Infiltrating Lymphocytes as Predictive Biomarker in Breast Cancer

Immune cells known as

tumor-infiltrating lymphocytes (tils) promising biomarker

1

Watch Now

Breast Cancer • 45 Min Watch

Tumor Infiltrating Lymphocytes as Predictive Biomarker in Breast Cancer

Immune cells known as

tumor-infiltrating lymphocytes (tils) promising biomarker

1

Watch Now

Breast Cancer • 18 Min Watch

ABC-6 Guidelines : An Overview , Part -1

International Consensus Conference for Advanced Breast Cancer (ABC): publishes consensus-based guidelines which are adopted and adapted by m...

abc -6 guidelines cancer related cognitive impairment endocrine resistance oligometastatic disease

5

Watch Now

Breast Cancer • 18 Min Watch

ABC-6 Guidelines : An Overview , Part -1

International Consensus Conference for Advanced Breast Cancer (ABC): publishes consensus-based guidelines which are adopted and adapted by m...

abc -6 guidelines cancer related cognitive impairment endocrine resistance oligometastatic disease

5

Watch Now

MedCourse • 10 Min Watch

Hot topics em doenças infecciosas: abordagem prática e desafios emergentes

Hot topics em doenças infecciosas: abordagem prática e desafios emergentes

tipos de imunodeficiências/imunossupressores visão geral infecções associadas a transplantes de órgãos sólidos melhorando o diagnóstico infecções virais fúngicas

1

Watch Now

MedCourse • 12 Min Watch

Infecções MRSA & VRSA: epidemiologia, resistência, mecanismos, diagnóstico, guidelines e conduta terapêutica

Epidemiologia, Resistência e mecanismos & Diagnóstico de MRSA e VRSA

mrsa e vrsa

1

Watch Now

Multiple Myeloma • 18 Min Watch

Exploring Optimal Duration of Lenalidomide Maintenance after ASCT

Best evidence for Lenalidomide maintenance after ASCT came from Meta-analysis of 3 trials (McCarthy et al, JCO 207) confirmed significant OS benefit w...

lenalidomide maintenance myeloma XI duration of maintenance

0

Watch Now

Multiple-Myeloma • 22 Min Watch

Importance of identifying High Risk Patients in Multiple Myeloma

N/A

high risk myeloma

2

Watch Now

Myelodysplastic Syndromes • 00 Min Watch

Factors that influence treatment adherence and outcomes in MDS

Anticipate & manage adverse events to optimize treatment outcomes: Patients treated with hypomethylating agents are at increased risk of cytopenias & ...

adverse events hypomethylating agents mds treatment compliance

0

Watch Now

Myelodysplastic Syndromes • 38 Min Watch

Duration of treatment does it improve outcomes Hypomethylating agents in MD

.

duration of treatment hypomethylating agents mds

1

Watch Now
Hi, can I help?
Chat SupportX
Support Team
Hello, how can I help you today?
Please select one of the below options.

Find Information

Unable to Login or Register

Want to share feedback